On April 19, 2016, the President signed three bills into law. The first is S. 192, the "Older Americans Act Reauthorization Act of 2016," which modifies grant programs for services to the elderly under the Older Americans Act of 1965. The second is S. 483, the "Ensuring Patient Access and Effective Drug Enforcement Act of 2016," which amends the Controlled Substances Act to define "imminent danger to public health or safety" and provide registrants with the opportunity to submit a corrective action plan. The third is S. 2512, the "Adding Zika Virus to the FDA Priority Review Voucher Program Act," which adds Zika virus to the Food and Drug Administration priority review voucher program to encourage the development of treatments for neglected tropical diseases.